
Biological and Pharmaceutical Bulletin p. 105 - 108 (1998)
Update date:2022-08-05
Topics:
Tada, Mayako
Wanaka, Keiko
Okamoto, Shosuke
Okamoto, Utako
Nakaya, Yukiko
Horie, Noboru
Hijikata-Okunomiya, Akiko
Tsuda, Yuko
Okada, Yoshio
We synthesized a new affinity gel (PKSI-Toyopearl) using a selective synthetic inhibitor of plasma kallikrein (PKSI-527) as an affinity ligand, and employed it for the rapid purification of plasma kallikrein from human plasma. Human plasma activated with kaolin after acid treatment was applied to a PKSI-Toyopearl column. Adsorbed protein was eluted with 50 mM glycine- hydrochloric acid buffer (pH 3.0). Plasma kallikrein was purified 181-fold with a yield of 85% from the kaolin-activated plasma. Further purification was performed by chromatography on a DEAE-Toyopearl 650M column. Plasma kallikrein was finally purified 1720-fold with a 63% yield by these procedures. On sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis, a band was observed at approximately 88 kDa. These findings indicate that PKSI-Toyopearl is a valuable tool for the purification of plasma kallikrein from human plasma.
Contact:+ 86 512 52491118
Address:1 Fuyu Road, Haiyu TownChangshu, Jiangsu, China
Shanghai Hongbang Medical Technology CO.,. Ltd
Contact:13671516988 /18917636693
Address:Room1, No67 Building, Yongde Road369, Wujing Town, Minhang Districy, Shanghai CIty, China.
Suzhou Ryan Pharmachem Technology Co.,Ltd
Contact:+86-0512-68780025
Address:B-301,No.2 Taishan Road,Suzhou New District,Jiangsu,P.R. China
Contact:13357117572
Address:No.149 Shiji dadao Road.
Tianjin Ji Ping Jia Chemical Co., Ltd.
Contact:18622448868
Address:tianjin
Doi:10.1081/SIM-120039270
(2004)Doi:10.1081/SCC-200030965
(2004)Doi:10.1002/jps.2600700803
(1981)Doi:10.1021/jo00339a026
(1981)Doi:10.1039/P19810002253
(1981)Doi:10.1039/d0md00049c
(2020)